MedTrace Logo

Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.

NCT03553251 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-06-12

No results posted yet for this study

Summary

The purpose of this study is to establish the rationale for the practice of performing an oral reintroduction test without previous skin tests in children at low risk of IgE-mediated reaction or drug-induced toxidermia, and to confirm the criteria for a drug reintroduction test could be performed without previous skin tests, without subsequent risk of reaction for the child. The primary endpoint will be the risk of a severe IgE-mediated or delayed hypersensitivity reaction in children who received beta-lactam drug reintroduction protocol prior to skin testing.

Conditions

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-30
Primary Completion
2019-07-30
Completion
2019-07-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03553251 on ClinicalTrials.gov